"Implementing RCM solutions that will help us navigate the reimbursement and regulatory complexities of the molecular diagnostics market is critical to drive rapid company growth. XIFIN was the clear choice because the company has a solid reputation for achieving results, powerful web service technology, and a leadership team recognized for change advocacy and reform in the molecular DX and diagnostic services market. I am confident that our partnership with XIFIN will provide the framework we need to strategically manage our operations and drive growth and profitability."